top of page
Media & Events
Dexa Group's Commitment to Supporting Indonesia's Healthcare Independence through the Development of Natural Medicines
As a leading national pharmaceutical company, Dexa Group plays a crucial role in advancing Indonesia’s healthcare independence and resilienc
Nov 8, 2024
House Commission IX of the Republic of Indonesia Commends Phyto-pharmaceutical Production Facility and Advocates for Inclusion of Indigenous Modern Medicines in National Health Insurance
In an effort to bolster the resilience and quality of the national pharmaceutical industry, the House of Representatives Commission IX, led
Nov 8, 2024
Dexa Group Promotes Domestic Products by Showcasing OMAI at National Event
Dexa Group, as one of the leading national pharmaceutical companies committed to advancing the domestic industry, participated in the Nation
Oct 10, 2024
Visit to Dexa Site Cikarang: BPOM Head Affirms Support for OMAI in JKN
The Head of the Indonesian Food and Drug Authority (BPOM), Mr. Taruna Ikrar, conducted a working visit to Dexa Site Cikarang
Sep 28, 2024
Dexa Group Fosters Natural Medicine MSMEs, BPOM Appreciates Natural Medicine Manufacturers through Strengthening Independence
Dexa Group and other Natural Medicine (OBA) industries have received appreciation from the Indonesian Food and Drug Authority (BPOM)
Aug 5, 2024
Ensuring the Quality of Dexa Group Medicines: Indonesian Society of Neurosurgeons Visits DLBS and DSCM
The Central Board of the Indonesian Society of Neurosurgeons (PERSPEBSI) visited the Dexa Laboratories of Biomolecular Sciences (DLBS)
Jun 4, 2024
bottom of page